Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases

Miao-Miao Lin1, Na Liu1, Zheng-Hong Qin1

  • 1Department of Pharmacology and Laboratory of Aging and Nervous Diseases and Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Insights

Mitochondrial dysfunction and neuroinflammation are key in neurodegeneration. Understanding their links, like mitochondrial DAMPs triggering inflammation, offers new therapeutic targets for these diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Mitochondrial dysfunction and neuroinflammation are hallmarks of neurodegenerative diseases.
  • Evidence highlights intricate crosstalk between cellular energy production and immune responses in the brain.
  • Mitochondrial damage-associated molecular patterns (DAMPs) and glial inflammatory factors mediate this interaction.

Purpose of the Study:

  • To review the molecular mechanisms linking mitochondrial dysfunction and neuroinflammation in neurodegeneration.
  • To elucidate the role of mitochondrial-derived DAMPs in exacerbating neuroinflammation.
  • To identify potential therapeutic targets by understanding this complex interplay.

Main Methods:

  • Literature review focusing on molecular mechanisms.
  • Analysis of studies detailing the bidirectional communication between mitochondria and glial cells.
  • Compilation of evidence on specific mitochondrial components acting as DAMPs.

Main Results:

  • Mitochondrial dysfunction often precedes and drives neuroinflammation in disease progression.
  • Mitochondrial DAMPs, including mtDNA, mtUPR, mtROS, ATP, TFAM, cardiolipin, cytochrome c, mitochondrial Ca2+, and iron, activate microglial immune responses.
  • Neuroinflammation, in turn, modulates mitochondrial metabolism and function via inflammatory mediators.

Conclusions:

  • The dynamic crosstalk between mitochondrial dysfunction and neuroinflammation is central to neurodegenerative disease pathogenesis.
  • Targeting mitochondrial-derived DAMPs or the inflammatory pathways they activate presents promising therapeutic strategies.
  • Further research into these specific molecular links is crucial for developing effective treatments for neurodegenerative conditions.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...